Metabolic Profiling and Quantitative Analysis of Cerebrospinal Fluid Using Gas Chromatography–Mass Spectrometry: Current Methods and Future Perspectives
Open Access
Abstract
Cerebrospinal fluid is a key biological fluid for the investigation of new potential biomarkers of central nervous system diseases. Gas chromatography coupled to mass-selective detectors can be used for this investigation at the stages of metabolic profiling and method development. Different sample preparation conditions, including extraction and derivatization, can be applied for the analysis of the most of low-molecular-weight compounds of the cerebrospinal fluid, including metabolites of tryptophan, arachidonic acid, glucose; amino, polyunsaturated fatty and other organic acids; neuroactive steroids; drugs; and toxic metabolites. The literature data analysis revealed the absence of fully validated methods for cerebrospinal fluid analysis, and it presents opportunities for scientists to develop and validate analytical protocols using modern sample preparation techniques, such as microextraction by packed sorbent, dispersive liquid–liquid microextraction, and other potentially applicable techniques.Keywords
Funding Information
- Council on grants of the President of the Russian Federation (MK-627.2020.7.)
- Ministry of Science and Higher Education (Russian Federation) (0563-2019-0020)
This publication has 115 references indexed in Scilit:
- GC/MS-based metabolomic analysis of cerebrospinal fluid (CSF) from glioma patientsJournal of Neuro-Oncology, 2013
- Multi-platform characterization of the human cerebrospinal fluid metabolome: a comprehensive and quantitative updateGenome Medicine, 2012
- Phospholipids and insulin resistance in psychosis: a lipidomics study of twin pairs discordant for schizophreniaGenome Medicine, 2012
- Investigation of urinary volatile organic metabolites as potential cancer biomarkers by solid-phase microextraction in combination with gas chromatography-mass spectrometryBritish Journal of Cancer, 2011
- Metabolomics of cerebrospinal fluid reveals changes in the central nervous system metabolism in a rat model of multiple sclerosisMetabolomics, 2011
- Disease-Related Changes in the Cerebrospinal Fluid Metabolome in Amyotrophic Lateral Sclerosis Detected by GC/TOFMSPLOS ONE, 2011
- Quantitative metabolomics based on gas chromatography mass spectrometry: status and perspectivesMetabolomics, 2010
- Cerebrospinal fluid evidence of increased extra-mitochondrial glucose metabolism implicates mitochondrial dysfunction in multiple sclerosis disease progressionJournal of the Neurological Sciences, 2008
- Cerebrospinal Fluid Dehydroepiandrosterone Levels Are Correlated with Brain Dehydroepiandrosterone Levels, Elevated in Alzheimer’s Disease, and Related to Neuropathological Disease StageThe Journal of Clinical Endocrinology & Metabolism, 2008
- N-acetylaspartic acid in cerebrospinal fluid of multiple sclerosis patients determined by gas-chromatography-mass spectrometryJournal of Neurology, 2007